FLUTICASONE FUROATE/UMECLIDINIUM/VILANTEROL VS OPEN TRIPLE THERAPY FOR TREATING SEVERE TO VERY SEVERE CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) FROM A BRAZILIAN PUBLIC HEALTHCARE PERSPECTIVE: A BUDGET IMPACT ANALYSIS

被引：0
|
作者：
Araujo, M. [1 ]
Bernardino, G. [1 ]
Tanaka, S. Y. [1 ]
机构：
[1] GSK, Rio De Janeiro, RJ, Brazil
来源：
VALUE IN HEALTH | 2024年 / 27卷 / 06期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
EE512
引用
收藏
页码：S151 / S151
页数：1
相关论文
共 23 条
  • [21] COST-MINIMIZATION ANALYSIS AND BUDGET IMPACT OF GLYCOPYRRONIUM BROMIDE VERSUS TIOTROPIUM BROMIDE AS A MAINTENANCE BRONCHODILATOR TREATMENT IN PATIENTS WITH MODEREATE TO SEVERE CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)
    Ruiz Miranda, C., I
    Ubiarco Lopez, V
    Chavez Plascencia, E.
    VALUE IN HEALTH, 2015, 18 (03) : A174 - A174
  • [22] Effects of mometasone furoate/formoterol fumarate fixed-dose combination formulation on chronic obstructive pulmonary disease (COPD): results from a 52-week Phase III trial in subjects with moderate-to-very severe COPD
    Doherty, Dennis E.
    Tashkin, Donald P.
    Kerwin, Edward
    Knorr, Barbara A.
    Shekar, Tulin
    Banerjee, Sibabrata
    Staudinger, Heribert
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2012, 7 : 57 - 71
  • [23] Cost-Effectiveness of Triple Therapy with Budesonide/Glycopyrronium/Formoterol Fumarate Dihydrate versus Dual Therapies in Moderate-to-Very Severe Chronic Obstructive Pulmonary Disease: United Kingdom Analysis Using the ETHOS Study
    De Nigris, Enrico
    Treharne, Catrin
    Brighton, Nick
    Holmgren, Ulf
    Walker, Andrew
    Haughney, John
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2022, 17 : 2987 - 3000
123